About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Renal Mechanism of Action/Splay vs. TmG

Renal Mechanism of Action/Splay vs. TmG

NCT00726505·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

With

Bristol-Myers Squibb

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Male and female subjects
Age 18 to 65 years
BMI 18 to 35 kg/m2
Healthy subjects and subjects with type 2 diabetes mellitus on 1 of the following therapies: diet, sulfonylurea, and/or metformin
No evidence of impaired renal function

You may not be if

Unwilling or unable to use an acceptable method of birth control
Subjects with type 1 diabetes mellitus, heart disease, hepatic C or B
Exposure to insulin
Use of exclusionary concomitant medications
Evidence of significant kidney disease or any other significant medical or psychiatric disorder

The record

StatusTerminated

PhasePhase 1

Taking part1

StartedJun 2009

UpdatedOct 17, 2016

Conditions

Where1

University Of Texas Health Center At San Antonio
San Antonio, Texas, United States